Phase 2b study of KBP-5074 for cardiovascular disease

Trial Profile

Phase 2b study of KBP-5074 for cardiovascular disease

Phase of Trial: Phase II

Latest Information Update: 10 Jan 2018

At a glance

  • Drugs KBP 5074 (Primary)
  • Indications Cardiovascular disorders; Renal hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jan 2018 New trial record
    • 05 Jan 2018 According to KBP Biosciences media release, trial is expected to start in early 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top